Live From WCLC 2024: Monday Highlights Podcast

Podcast | English | 2024 | 37 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Narjust Florez discusses daily highlights from the conference. Dr. Xiuning Le reports updated results of BAY 292708, and Dr. Gerrina Ruiter summarizes the Beamion LUNG-1 study, both of which evaluate the efficacy of therapies for patients with HER2-Mutant NSCLC. Dr. Fiona Hegi-Johnson adds her perspective as a discussant of the POLESTAR trial evaluating EGFR therapy after chemoradiation in stage III unresectable NSCLC.

Podcast Host:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA

Podcast Guests:

Xiuning Le, MD, PhD, Associate Professor in the Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Gerrina Ruiter, MD, PhD, Pulmonologist Specialized in Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands
Fiona Hegi-Johnson, MD, Senior Research Fellow, University of Melbourne, Melbourne, Australia